Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03756012 · ClinicalTrials.gov registry record · NA
Evaluation of Clinical Outcomes of Pulse Widths in Spinal Cord Stimulation
A NA study, sponsored by Kettering Health Network.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03756012: Completed NA study, sponsored by Kettering Health Network.
NCT03756012 is a NA study that has completed, run by Kettering Health Network. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03756012, a NA study, has completed, sponsored by Kettering Health Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of pulse widths \<500 μsec and \>1000 μsec on clinical outcomes during a temporary SCS trial.
Primary Outcome
To evaluate the effect of conventional pulse widths \<500 μsec and pulse widths \>1000 μsec on clinical outcomes during temporary trial as measured by patient defined pain maps.
Interventions
- DEVICE Algovita Spinal Cord Stimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2019-10-02 |
| Phase | NA |
What the finished NCT03756012 record still lists
NCT03756012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Algovita Spinal Cord Stimulation System is the first listed.
NCT03756012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03756012 about?
NCT03756012 is a clinical study titled "Evaluation of Clinical Outcomes of Pulse Widths in Spinal Cord Stimulation". The purpose of this study is to evaluate the effect of pulse widths \<500 μsec and \>1000 μsec on clinical outcomes during a temporary SCS trial.
What is the current status of trial NCT03756012?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-11-27. Estimated completion is 2019-10-02.
What interventions are being tested in trial NCT03756012?
The interventions under investigation include: Algovita Spinal Cord Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT03756012?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03756012's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI